http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0472526-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-46
filingDate 1990-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15ab2ebca2575383a1dff8ffe58f1d7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e9c90302a84fbc12e5e24c570a0b517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1fef18d0f698285dacdcbd12bf4ebde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efe73afecf88e98c36aa00bb6550b4f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f205df05d3daca1c456be32d920b80c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30dfb79e9e3ffd314b06d0f6b2f99445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_853a3d7963848d12056f9fe1f791ce59
publicationDate 1996-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0472526-B1
titleOfInvention 5-AMINOCARBONYL-5H-DIBENZO a,d]CYCLOHEPTEN-5,10-IMINES FOR TREATMENT OF EPILEPSY AND COCAINE ADDICTION
abstract This invention is in the field of clinical neurology and relates specifically to compounds, compositions and methods for treatment of patients with generalized epilepsy or partial (symptomatic) epilepsy using compounds of formula (I). This invention also relates to compounds, compositions and methods of treatment for drug craving in patients addicted to cocaine.
priorityDate 1989-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128144382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID619818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129133037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234494362
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88404740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88404716
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230354166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129258565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226516535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234493856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234494246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127692443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14271439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5760
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127772503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128916926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228173200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13225427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127838758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227655175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129937523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID520047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234083054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410877
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18942829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128706830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324845

Total number of triples: 87.